Literature DB >> 17361229

Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes.

E Scquizzato1, A Teramo, M Miorin, M Facco, F Piazza, F Noventa, L Trentin, C Agostini, R Zambello, G Semenzato.   

Abstract

Using polymerase chain reaction (PCR)-based sequence-specific primers, the killer immunoglobulin-like receptor (KIR) genotypes of 35 patients with natural killer (NK)-type lymphoproliferative disease of granular lymphocytes and of 50 normal subjects were investigated to evaluate whether genes coding for activating KIRs were more frequently detected in patients with NK-lymphoproliferative disease of granular lymphocytes (LDGL). Genotype frequency indicated that the most frequently found gene content was eight genes in controls and 14 in patients (P<0.05). The KIR genotype analysis revealed that patient and, surprisingly, control KIR genotypes preferentially consisted of type B haplotypes characterized by the presence of multiple-activating KIRs. Evidence was also provided that the same KIR genotype was shared by a variable number of patients. Interestingly, the recurrent genotypes observed in the patient group were not found in controls. Concerning inhibitory genes, KIR2DL5a and 2DL5b were more frequently detected in patients than in controls (P<0.01), likely representing a discrete feature of the genetic repertoire of the patients. KIR gene repertoire analysis in patients suggests that the susceptibility to NK-LDGL might be related to the presence of activating KIR genes and supports the concept that these receptors may be involved in the priming of granular lymphocytes (GL) proliferation. Population analysis might disclose a genetic background predisposing to this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361229     DOI: 10.1038/sj.leu.2404634

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  15 in total

Review 1.  Natural killer cells in human autoimmune diseases.

Authors:  Nicolas Schleinitz; Frédéric Vély; Jean-Robert Harlé; Eric Vivier
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 2.  Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.

Authors:  James O J Davies; Kate Stringaris; A John Barrett; Katayoun Rezvani
Journal:  Cytotherapy       Date:  2014-05-20       Impact factor: 5.414

3.  Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.

Authors:  Renato Zambello; Gianpietro Semenzato
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

Review 4.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

5.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

6.  Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes.

Authors:  Cristina Gattazzo; Antonella Teramo; Marta Miorin; Elisa Scquizzato; Anna Cabrelle; Mirna Balsamo; Carlo Agostini; Elena Vendrame; Monica Facco; Maria Paola Albergoni; Livio Trentin; Massimo Vitale; Gianpietro Semenzato; Renato Zambello
Journal:  Haematologica       Date:  2010-04-21       Impact factor: 9.941

7.  Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.

Authors:  E Poullot; R Zambello; F Leblanc; B Bareau; E De March; M Roussel; M L Boulland; R Houot; A Renault; T Fest; G Semenzato; T Loughran; T Lamy
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

Review 8.  The Yin and Yang of HLA and KIR in human disease.

Authors:  Smita Kulkarni; Maureen P Martin; Mary Carrington
Journal:  Semin Immunol       Date:  2008-07-16       Impact factor: 11.130

9.  Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.

Authors:  Cristina Gattazzo; Antonella Teramo; Francesca Passeri; Elena De March; Samuela Carraro; Valentina Trimarco; Federica Frezzato; Tamara Berno; Gregorio Barilà; Veronica Martini; Francesco Piazza; Livio Trentin; Monica Facco; Gianpietro Semenzato; Renato Zambello
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

Review 10.  Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?

Authors:  Renato Zambello; Antonella Teramo; Gregorio Barilà; Cristina Gattazzo; Gianpietro Semenzato
Journal:  Front Immunol       Date:  2014-02-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.